The role of CXCR3 and its chemokine ligands in skin disease and cancer
Chemokines and their receptors play an important role in the recruitment, activation and
differentiation of immune cells. The chemokine receptor, CXCR3, and its ligands, CXCL9 …
differentiation of immune cells. The chemokine receptor, CXCR3, and its ligands, CXCL9 …
Cutaneous manifestations of “lupus”: systemic lupus erythematosus and beyond
EE Cooper, CE Pisano… - International Journal of …, 2021 - Wiley Online Library
Lupus, Latin for “wolf,” is a term used to describe many dermatologic conditions, some of
which are related to underlying systemic lupus erythematosus, while others are distinct …
which are related to underlying systemic lupus erythematosus, while others are distinct …
Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases
Analysis of gene expression from cutaneous lupus erythematosus, psoriasis, atopic
dermatitis, and systemic sclerosis using gene set variation analysis (GSVA) revealed that …
dermatitis, and systemic sclerosis using gene set variation analysis (GSVA) revealed that …
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
ECS Vale, LC Garcia - Anais Brasileiros de Dermatologia, 2023 - SciELO Brasil
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression,
which may present as an exclusively cutaneous disease or be one of the multiple …
which may present as an exclusively cutaneous disease or be one of the multiple …
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus
V Erazo-Martínez, GJ Tobón, CA Cañas - Autoimmunity Reviews, 2023 - Elsevier
Cutaneous lupus erythematosus (CLE) is a common disease that may appear as a separate
entity from systemic lupus erythematosus (SLE), precede SLE development, or occur as a …
entity from systemic lupus erythematosus (SLE), precede SLE development, or occur as a …
Topographic differential diagnosis of chronic plaque psoriasis: challenges and tricks
Background: Psoriasis is an inflammatory skin disease presenting with erythematous and
desquamative plaques with sharply demarcated margins, usually localized on extensor …
desquamative plaques with sharply demarcated margins, usually localized on extensor …
Orofacial manifestations and dental management of systemic lupus erythematosus: A review
Systemic lupus erythematosus (SLE) is an autoimmune multisystem disease with numerous
clinical manifestations. There is no consensus about the ideal oral management for this …
clinical manifestations. There is no consensus about the ideal oral management for this …
Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes
CC Berthier, LC Tsoi, TJ Reed, JN Stannard… - Journal of clinical …, 2019 - mdpi.com
Cutaneous lupus erythematosus (CLE) is a common manifestation of systemic lupus
erythematosus (SLE), and CLE can also develop without systemic involvement. CLE can be …
erythematosus (SLE), and CLE can also develop without systemic involvement. CLE can be …
Connection between celiac disease and systemic lupus erythematosus in children—A development model of autoimmune diseases starting from what we inherit to …
Celiac disease (CD) and systemic lupus erythematosus (SLE) are two diseases intensively
studied in all age groups, with an increasing incidence at the global level, possibly due to …
studied in all age groups, with an increasing incidence at the global level, possibly due to …
Review of an anti-CD20 monoclonal antibody for the treatment of autoimmune diseases of the skin
S Ly, D Nedosekin, HK Wong - American journal of clinical dermatology, 2023 - Springer
Biologic therapies targeting B-cells are emerging as an effective strategy to treat a variety of
immune-mediated diseases. One of the most studied B-cell-targeted therapies is rituximab …
immune-mediated diseases. One of the most studied B-cell-targeted therapies is rituximab …